Insider Selling: Trupanion (NASDAQ:TRUP) CFO Sells 6,177 Shares of Stock

Trupanion, Inc. (NASDAQ:TRUP) CFO Fawwad Qureshi sold 6,177 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total value of $137,005.86. Following the transaction, the chief financial officer owned 2,081 shares of the company’s stock, valued at approximately $46,156.58. This represents a 74.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Fawwad Qureshi also recently made the following trade(s):

• On Friday, February 27th, Fawwad Qureshi sold 2,837 shares of Trupanion stock. The shares were sold at an average price of $26.46, for a total value of $75,067.02.

Trupanion Stock Down 0.8%

Shares of NASDAQ TRUP traded down $0.17 during mid-day trading on Wednesday, hitting $21.69. The company had a trading volume of 371,901 shares, compared to its average volume of 428,641. The company has a market capitalization of $946.12 million, a PE ratio of 36.76 and a beta of 1.49. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73. Trupanion, Inc. has a 1-year low of $21.16 and a 1-year high of $57.88. The business’s 50-day simple moving average is $25.08 and its 200 day simple moving average is $30.52.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.04. The business had revenue of $384.05 million for the quarter, compared to analysts’ expectations of $379.77 million. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same period last year, the firm earned ($0.03) earnings per share. On average, analysts predict that Trupanion, Inc. will post 0.53 earnings per share for the current year.

Institutional Trading of Trupanion

Hedge funds and other institutional investors have recently bought and sold shares of the business. GSA Capital Partners LLP raised its stake in Trupanion by 827.3% in the third quarter. GSA Capital Partners LLP now owns 44,584 shares of the financial services provider’s stock valued at $1,930,000 after buying an additional 39,776 shares in the last quarter. Tudor Investment Corp ET AL raised its stake in Trupanion by 183.7% in the third quarter. Tudor Investment Corp ET AL now owns 237,125 shares of the financial services provider’s stock valued at $10,263,000 after buying an additional 153,530 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in shares of Trupanion during the third quarter worth about $1,897,000. Dynamic Technology Lab Private Ltd increased its position in shares of Trupanion by 94.1% during the third quarter. Dynamic Technology Lab Private Ltd now owns 44,666 shares of the financial services provider’s stock worth $1,934,000 after purchasing an additional 21,656 shares in the last quarter. Finally, Kopion Asset Management LLC increased its position in shares of Trupanion by 11.0% during the fourth quarter. Kopion Asset Management LLC now owns 293,706 shares of the financial services provider’s stock worth $10,976,000 after purchasing an additional 29,103 shares in the last quarter.

Analyst Upgrades and Downgrades

TRUP has been the topic of several analyst reports. Stifel Nicolaus reduced their price objective on Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a research note on Tuesday, March 31st. Bank of America cut their price target on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research note on Tuesday, April 14th. Piper Sandler cut their price target on Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Cantor Fitzgerald cut their price target on Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research note on Thursday, April 9th. Finally, Zacks Research cut Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 13th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Trupanion presently has an average rating of “Hold” and an average target price of $42.25.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.